DR. FRANCISCA V. LYTLE, M.D.

Plain English
This study looked at how the MELD score, which typically measures liver disease severity, can help predict the chances of survival in patients with heart problems who are treated with a device called veno-arterial extracorporeal membrane oxygenation (VA ECMO). Out of 194 patients, 62.1% died within 90 days, and researchers found that higher MELD scores were strongly linked to higher mortality rates, with a significant increase in risk of death for each point increase in the score. This is important because it suggests that the MELD score could be a valuable tool for doctors to assess which patients might be at greater risk after receiving VA ECMO. Who this helps: This helps doctors treating patients with severe heart issues and those who might need VA ECMO.

Plain English
This study examined patients who experienced cardiogenic shock and required a special life-support treatment called extracorporeal membrane oxygenation (ECMO). Out of 661 patients who survived and were discharged after ECMO, 158 (about 24%) were readmitted to the hospital within 30 days, with more than half of those readmissions occurring within the first 11 days. The main reasons for these readmissions were heart issues, complications from treatment, infections, and gastrointestinal problems, highlighting the need to identify which patients are most at risk for readmission. Who this helps: This research helps doctors understand which patients are more likely to need additional hospital care after treatment, allowing them to provide better follow-up and support.